Radiopaque embolic particles
A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ abl...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BOYD DANIEL ABRAHAM ROBERT J KEHOE SHARON |
description | A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ613872A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ613872A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ613872A3</originalsourceid><addsrcrecordid>eNrjZJAJSkzJzC9ILCxNVUjNTcrPyUxWKEgsKslMzkkt5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5RZobGFuZGjsYEFQAA7G4i7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Radiopaque embolic particles</title><source>esp@cenet</source><creator>BOYD DANIEL ; ABRAHAM ROBERT J ; KEHOE SHARON</creator><creatorcontrib>BOYD DANIEL ; ABRAHAM ROBERT J ; KEHOE SHARON</creatorcontrib><description>A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.</description><language>eng</language><subject>CHEMISTRY ; COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F ; COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM ; COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS ; COMPOUNDS THEREOF ; HUMAN NECESSITIES ; HYGIENE ; INORGANIC CHEMISTRY ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NON-METALLIC ELEMENTS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160129&DB=EPODOC&CC=NZ&NR=613872A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160129&DB=EPODOC&CC=NZ&NR=613872A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BOYD DANIEL</creatorcontrib><creatorcontrib>ABRAHAM ROBERT J</creatorcontrib><creatorcontrib>KEHOE SHARON</creatorcontrib><title>Radiopaque embolic particles</title><description>A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.</description><subject>CHEMISTRY</subject><subject>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</subject><subject>COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM</subject><subject>COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS</subject><subject>COMPOUNDS THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INORGANIC CHEMISTRY</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NON-METALLIC ELEMENTS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJSkzJzC9ILCxNVUjNTcrPyUxWKEgsKslMzkkt5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5RZobGFuZGjsYEFQAA7G4i7g</recordid><startdate>20160129</startdate><enddate>20160129</enddate><creator>BOYD DANIEL</creator><creator>ABRAHAM ROBERT J</creator><creator>KEHOE SHARON</creator><scope>EVB</scope></search><sort><creationdate>20160129</creationdate><title>Radiopaque embolic particles</title><author>BOYD DANIEL ; ABRAHAM ROBERT J ; KEHOE SHARON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ613872A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</topic><topic>COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM</topic><topic>COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS</topic><topic>COMPOUNDS THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INORGANIC CHEMISTRY</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NON-METALLIC ELEMENTS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BOYD DANIEL</creatorcontrib><creatorcontrib>ABRAHAM ROBERT J</creatorcontrib><creatorcontrib>KEHOE SHARON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BOYD DANIEL</au><au>ABRAHAM ROBERT J</au><au>KEHOE SHARON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Radiopaque embolic particles</title><date>2016-01-29</date><risdate>2016</risdate><abstract>A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_NZ613872A |
source | esp@cenet |
subjects | CHEMISTRY COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS COMPOUNDS THEREOF HUMAN NECESSITIES HYGIENE INORGANIC CHEMISTRY MEDICAL OR VETERINARY SCIENCE METALLURGY NON-METALLIC ELEMENTS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Radiopaque embolic particles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A44%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BOYD%20DANIEL&rft.date=2016-01-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ613872A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |